# Atracurium Besylate

NDC: 55150-217
Generic name: Atracurium Besylate
Labeler / Manufacturer: AuroMedics Pharma LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20150408

FDA application: ANDA206011

## Active ingredients

- ATRACURIUM BESYLATE: 100 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-217"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-217
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7b6a720-05a7-4d6a-9200-21bdc90fc1c4